Author: Marie Jones

Tianyun International Holdings Limited (“Tianyun International”, together with its subsidiaries, the “Group”, Stock code: 6836.HK), a leading seller and manufacturer of processed fruits products in China, is pleased to announce, the Group’s auditor, Messrs. PricewaterhouseCoopers has completed its audit of the unaudited annual results of the Group for the year ended 31 December 2019 in accordance with Hong Kong Standards on Auditing issued by the Hong Kong Institute of Certified Public Accountants (“HKICPA”), including the financial figures in respect of the Group’s consolidated statement of financial position, consolidated statement of comprehensive income and the related notes thereto as set out…

On April 15, 2020, MicroPort Scientific Corporation (Stock code: 00853) (“MicroPort”), announced that MicroPort CardioFlow Medtech Corporation (“MicroPort CardioFlow”), which is a subsidiary of MicroPort, had completed raising a new round of funds on the basis of a pre-money valuation of US$1.1 billion. The introduction of seven prominent strategic investors, who are CPE, Hillhouse Capital Management, Ltd., Lake Bleu Capital, Gamnat, China Reform Conson Soochow Overseas Fund I L.P., Gortune Artemis Limited, and 3H Health Investment Fund I, L.P., raised approximately US$130 million. After this round of fundraising, the investors will have an aggregate shareholding of 10.83% in MicroPort CardioFlow.…

Achieve up to a 30% reduction in time to complete close tasks and up to a 99% reduction in time to support external auditors with Cadency Close Management As finance & accounting (F&A) teams adjust to a new way of working with a dispersed remote workforce, Trintech announces that its enterprise-grade Cadency Close Management solution will be available at no cost, for up to 6 months, to help large enterprises manage their close process virtually. With this offer, Trintech’s professional services team will assist in the implementation and configuration of the solution including building, organizing and importing your close checklist…

Brainhole Technology Limited (“Brainhole Tech” or the “Company”, together with its subsidiaries, the “Group”) (stock code: 2203) is committed to diversifying its business portfolio. While strengthening its research and development (“R&D”) and innovation capabilities in the semiconductor and hardware businesses, the Group has seized market opportunities for expanding to the smart living sector to generate cross-business synergies. Proactively expands to smart living sector At present, China is a world leader in 5G network technology, and has commenced full implementation of a 5G network for commercial and civilian applications in 2020. As technological innovation and development are highly encouraged and supported…

Leading Crypto Derivatives Platform targets significant growth in employee numbers to meet global user demand Crypto derivatives platform XMEX has announced the successful raising of $6 Million in a Series A funding. Investors that participated in the round include Circle Fund, Asia’s first fully compliant crypto fund and Kylin Prime Group, the Switzerland based investment group. An added strength of the investment agreement will also give XMEX the ability to draw on Circle Fund and Kylin Prime Group’s experience in global expansion and regional/local compliance requirements. CEO and Co-founder of XMEX, Allen Wong said: “The closure of our Series A…

Global Green Chemicals PCL (SET:GGC) Managing Director, Mr. Witoon Suewatanakul discusses the company’s strategy and outlook in The Executive Talk (TET) by ShareInvestor.com. TET: Please explain GGC’s business model. GGC’s aspiration is to become a leading Green Chemical Company. Being a listed company on the Stock Exchange of Thailand since 2017, GGC has embarked on investing in our products and capacity. Currently our two main businesses are biofuels and biochemicals which include Methyl Esther (ME), Fatty Alcohols (FA) and Glycerine. These products are commonly used in the automotive industry, personal care, home care, and pharmaceuticals. With our current investment projects,…

TOKYO, Apr 13, 2020 – (JCN Newswire) – Showa Denko (“Showa Denko”; TSE: 4004), National Institute of Advanced Industrial Science and Technology (AIST), New Energy and Industrial Technology Development Organization (NEDO) and Research Association of High-Throughput Design and Development for Advanced Functional Materials (ADMAT) have cooperatively proved that introduction of artificial intelligence (AI) into the process to develop flexible transparent film[1] can reduce the numbers of times of experiment to produce film that satisfies required properties to one-twenty-fifth (1/25) or less of those conventional development methods require. This development work has been subcontracted by NEDO’s “Ultra High-Throughput Design and Prototyping…

The leading luxury brand 4S dealership group in China, ZhengTong Auto (Stock code: 1728.HK) has appointed Mr. Tian Sheng, currently Vice President of Strategic Planning, as the Chief Operating Officer, with effect from April 5th, 2020, in charge of management of all automotive brands in Group’s portfolio. Graduating from Beijing Institute of Technology, Mr. Tian has laid a solid foundation in the industry and held senior management positions in both global leading automobile consulting firm and esteemed automakers for years, covering areas of strategic planning, government affairs, new energy vehicles, sales operation, dealership development and overall regional management. Mr. Tian…

Bityard, the world’s leading cryptocurrency contracts exchange, has officially launched. Having received a strategic $10 million investment from a US hedge fund, Bityard is creating a precedent in the industry with complex contracts and simple transactions. Bityard’s ambitions are to foster research and development in relevant forward-looking technologies, generate overseas market expansion, and encourage ecological construction around their brand name. Headquartered in Singapore, Bityard is licensed and regulated by Singapore’s ACRA, the American Money Services Businesses (MSBs), and Estonia’s MTR for the European Union. In Southeast Asia, Bityard will ride the waves of digital asset demand, and government-driven blockchain transacts.…

SYDNEY – (ACN Newswire) – Novotech has announced that the top 10 biotech sites in Australia were open for clinical trial activity with many sites modifying their practices to ensure continuity of operations. The data contained in the COVID-19 Australia Data Bulletin is part of a new series detailing the current status of trials in the Asia Pacific during the pandemic. Novotech CEO Dr John Moller said the Bulletin series taps local knowledge of fundamentals in the sector and shows which countries in the region are able to support clinical research for Novotech and its clients during this time. “While the situation…

Leading Australian CRO Avance Clinical said there was still strong demand from Asian and US sponsors, and commended Australian sites that had risen to the challenge to deliver for Avance Clinical clients during this difficult time. Avance Clinical is a medium-sized full-service CRO known for its nimble and collaborative approach, with more than 20-years of experience in managing early phase trials. Avance Clinical’s Chief Strategist Ben Edwards said a key factor in sponsor demand is the speed and attractive cost of running trials in Australia. In particular, they include: – The Australian Government financial rebate of more than 40% on…

SINGAPORE, Apr 8, 2020 – (ACN Newswire) – Spikes Asia today announces that the Festival will no longer take place in October 2020 as planned. The Festival of Creativity, Spikes Awards and Tangrams Strategy & Effectiveness Awards will be held in 2021 in Singapore and new dates will be announced shortly. The impact of the COVID-19 virus continues to affect the Asia Pacific region and the world. Health, economic, and societal concerns are determining the priorities of societies and businesses globally. Our community, across the creative marketing and media industries, is facing unparalleled challenges. The need to protect companies and people, and to support…

KUALA LUMPUR, Apr 7, 2020 – (ACN Newswire) – Web Commerce Communications Limited dba WebNIC, a leading Asian domain name registrar is expanding its services by partnering with Alibaba Cloud, the data intelligence backbone of Alibaba Group, to offer cloud computing service in the SEA region. As the first online channel reseller in the domain business of Alibaba Cloud, WebNIC aims to help bridge the technical gap of cloud computing for small and medium enterprises (SME) to drive stronger cloud adoption across all industries through this partnership with the largest cloud computing provider in APAC. The partnership will position WebNIC as a distributor of…

Mainz, Germany – (ACN Newswire) – A new type of sensor device from the German health technology company Digital Diagnostics AG can be used for immediate tests for the new SARS coronavirus. The SARS-CoV-2 MEMS 5 Minute Test(TM) is created as a pocket-size lab and can be used in four steps anywhere on-site by general practitioners, paramedics and nursing staff without any training. The first prototypes of the biosensor will be available by end of April with first production devices by mid-May. Compared to previously known rapid tests looking for the presence of antibodies in the test-liquid, the SARS-CoV-2 MEMS 5 Minute…

Tel Aviv, Israel, Apr 8, 2020 – (ACN Newswire) – via NEWMEDIAWIRE — SuperTrans Medical (“SuperTrans”), a privately held biopharmaceutical company with initial focus on the discovery and development of novel antibiotics, today announced that leading South Korean biopharma Mediforum Pharm (KOSDAQ: 047920) will make a $2M investment in SuperTrans. In return, Mediforum will collaborate with SuperTrans in the manufacturing and commercialization of SuperTrans’ products in Asia, including South Korea, China, and Japan. Additionally, Mediforum will fully commit and support SuperTrans’ future drug development programs. The SuperTrans technology was discovered by chemists Prof. Paul A Wender (Professor of Chemistry, School of Humanities and Sciences,…

Retail and Trade Brand Advocacy (RTBA), a non-governmental organisation that safeguards businesses from criminal conduct, says the travel restrictions, movement control order (MCO) and tighter scrutiny by enforcement agencies at border checkpoints and expressways have done nothing to disrupt the illicit trade supply chain in Malaysia. Heath Michael, Managing Director of RTBA, said: “Recent feedback from industries and enforcement agencies indicated that instances of illicit trade in Malaysia remain high as syndicates and perpetrators utilise innovative ways to circumvent the more intense spotlight cast by the authorities due to the Covid-19 pandemic.” “In the case of illicit tobacco trade in…

一家最初專注於研發新型抗生素的私營生物製藥公司SuperTrans Medical(“SuperTrans”)宣布，其獲得韓國領先的生物製藥公司Mediforum Pharm(“Mediforum”)200萬美元的投資。作為回報，SuperTrans將與Mediforum展開合作，允許其參與在亞洲(包括韓國、中國和日本)投產產品的生產和商業化。此外，Mediforum也將全力支持SuperTrans未來的藥品開發項目。 SuperTrans技術是由化學家Paul A Wender教授(斯坦福大學斯坦福醫學院化學與系統生物學教授，以及斯坦福大學化學與系統生物學教授)和Lynette Cegelski教授(人文與科學學院化學教授)發現的，兩位都是公司科學顧問委員會的成員。 Wender教授受到大自然啟發，研發出富含胍分子轉運體技術，已獲斯坦福大學 SuperTrans 及其合作夥伴Mediforum授權。這種技術方法可以幫助填補傳輸應急抗生素對多重藥的致病菌的空白。 此外，SuperTrans正在基於其傳輸技術完成對COVID-19治療作候選評估。候選化合物將旨在預防病毒和細菌性肺部感染。該公司目前正在準備此藥物開發計劃。 SuperTrans Medical的研發團隊由曾供職大型製藥公司的成功研發人員組成，其中不乏來自抗生素和HIV抑製劑製藥公司的研究人員。他們分別是首席執行官Lewis Neville博士、首席技術官Jacob Rendell博士(前Teva)、Patricia Bradford博士(前惠氏、諾華和阿斯利康)、Joseph Vacca博士(前默克和無錫Apptec)、Peter Warn博士(前Evotec)和兒科臨床傳染病專家Itamar Shalit教授。 Mediforum是一家總部位於首爾的製藥公司，專門研究和開發抗神經衰退性疾病(如阿爾茨海默病和帕金森病)的新藥。 “SuperTrans Medical很高興能與Mediforum合作——成為我們的主要戰略投資者。我們期待能與其建立長期的合作夥伴關係，以進一步開發和商業化SuperTrans技術。” SuperTrans公司首席執行官Lewis F. Neville評論道。“在很短的時間內，我們就在設計和評估FDA批准的不同抗生素方面取得了重大進展，並這些抗生素與公司獨特的SuperTrans技術結合在一起。我們從中發現了一些值得後期開發的化合物並進行了鑑定。Mediforum已經認識到我們平台技術的優勢，並藉此改善現有的FDA批准的抗生素的性能。Mediforum的投資將有望使一種領先的抗生素結合物在12-15個月內進入第一階段測試。” “我們很高興能投資SuperTrans。他們在過去幾個月裡迅速取得進展，這給我們留下了深刻的印象。受這些進展的啟發，我們得以進行一些鉛化合物的開發。我們相信，他們的SuperTrans技術可以成為一種轉變模型，助力應急抗生素進入人體試驗。Mediforum將通過所有研發工作的共享交流，積極發揮戰略合作夥伴的作用。儘管SuperTrans技術處於相對初級的發展階段，我們預計新一代抗生素的測試將相對較快。這是因為這項技術可以很輕鬆地與現有的FDA批准的抗生素結合，”Mediforum首席執行官Park Jaehyung先生評論道。“此外，SuperTrans正通過斯坦福大學和其他學者的支持來加強其渠道。另外，SuperTrans正為2022的香港IPO 做準備，這對Mediforum非常有吸引力，”Park Jaehyung先生補充評論道。 關於SuperTrans Medical SuperTrans Medical是一家生物製藥公司，通過改進現有的FDA化合物的性能，開發新型抗生素。該化合物與一種名為富含胍分子轉運體(GRMoTr)的獨特轉運體技術進行化學結合。有效抗生素開發的一個主要障礙是能否成功克服細菌外膜的結構複雜性。這與革蘭陰性菌關聯甚深。 GRMoTr賦予抗生素優異的進化能力，使其能打破外膜，有效根除革蘭氏陽性和革蘭氏陰性病原體，包括多重耐藥菌株。 關於Mediforum Mediforum Pharm 是一家專業的腦保健製藥公司，其研發出治療衰退性腦疾病，如阿爾茨海默氏症和帕金森氏症等。如今，隨著處方藥銷售量的快速增長，公司正在積極拓展研發渠道。此外，Mediforum正積極與海外研究機構合作，從而將業務擴展到海外，進而打入全球市場。 有關更多信息，請聯繫: Lewis F. Neville, PhD CEO SuperTrans Medical lewis@supertransmedical.com Eran Gilboa CFO SuperTrans Medical eran@supertransmedical.com

一家最初专注于研发新型抗生素的私营生物制药公司SuperTrans Medical(“SuperTrans”)宣布，其获得韩国领先的生物制药公司Mediforum Pharm(“Mediforum”)200万美元的投资。作为回报，SuperTrans将与Mediforum展开合作，允许其参与在亚洲(包括韩国、中国和日本)投产产品的生产和商业化。此外，Mediforum也将全力支持SuperTrans未来的药品开发项目。 SuperTrans技术是由化学家Paul A Wender教授(斯坦福大学斯坦福医学院化学与系统生物学教授，以及斯坦福大学化学与系统生物学教授)和Lynette Cegelski教授(人文与科学学院化学教授)发现的，两位都是公司科学顾问委员会的成员。Wender教授受到大自然启发，研发出富含胍分子转运体技术，已获斯坦福大学 SuperTrans 及其合作伙伴Mediforum授权。这种技术方法可以帮助填补传输应急抗生素对多重药的致病菌的空白。 此外，SuperTrans正在基于其传输技术完成对COVID-19治疗作候选评估。 候选化合物将旨在预防病毒和细菌性肺部感染。 该公司目前正在准备此药物开发计划。 SuperTrans Medical的研发团队由曾供职大型制药公司的成功研发人员组成，其中不乏来自抗生素和HIV抑制剂制药公司的研究人员。他们分别是首席执行官Lewis Neville博士、首席技术官Jacob Rendell博士(前Teva)、Patricia Bradford博士(前惠氏、诺华和阿斯利康)、Joseph Vacca博士(前默克和无锡Apptec)、Peter Warn博士(前Evotec)和儿科临床传染病专家Itamar Shalit教授。 Mediforum是一家总部位于首尔的制药公司，专门研究和开发抗神经衰退性疾病(如阿尔茨海默病和帕金森病)的新药。“SuperTrans Medical很高兴能与Mediforum合作——成为我们的主要战略投资者。我们期待能与其建立长期的合作伙伴关系，以进一步开发和商业化SuperTrans技术。” SuperTrans公司首席执行官Lewis F. Neville评论道。“在很短的时间内，我们就在设计和评估FDA批准的不同抗生素方面取得了重大进展，并这些抗生素与公司独特的SuperTrans技术结合在一起。我们从中发现了一些值得后期开发的化合物并进行了鉴定。Mediforum已经认识到我们平台技术的优势，并借此改善现有的FDA批准的抗生素的性能。Mediforum的投资将有望使一种领先的抗生素结合物在12-15个月内进入第一阶段测试。” “我们很高兴能投资SuperTrans。他们在过去几个月里迅速取得进展，这给我们留下了深刻的印象。受这些进展的启发，我们得以进行一些铅化合物的开发。我们相信，他们的SuperTrans技术可以成为一种转变模型，助力应急抗生素进入人体试验。Mediforum将通过所有研发工作的共享交流，积极发挥战略合作伙伴的作用。尽管SuperTrans技术处于相对初级的发展阶段，我们预计新一代抗生素的测试将相对较快。这是因为这项技术可以很轻松地与现有的FDA批准的抗生素结合，”Mediforum首席执行官Park Jaehyung先生评论道。“此外，SuperTrans正通过斯坦福大学和其他学者的支持来加强其渠道。另外，SuperTrans正为2022的香港IPO 做准备，这对Mediforum非常有吸引力，”Park Jaehyung先生补充评论道。 关于SuperTrans Medical SuperTrans Medical是一家生物制药公司，通过改进现有的FDA化合物的性能，开发新型抗生素。该化合物与一种名为富含胍分子转运体(GRMoTr)的独特转运体技术进行化学结合。有效抗生素开发的一个主要障碍是能否成功克服细菌外膜的结构复杂性。这与革兰阴性菌关联甚深。GRMoTr赋予抗生素优异的进化能力，使其能打破外膜，有效根除革兰氏阳性和革兰氏阴性病原体，包括多重耐药菌株。 关于Mediforum Mediforum Pharm 是一家专业的脑保健制药公司，其研发出治疗衰退性脑疾病，如阿尔茨海默氏症和帕金森氏症等。如今，随着处方药销售量的快速增长，公司正在积极拓展研发渠道。此外，Mediforum正积极与海外研究机构合作，从而将业务扩展到海外，进而打入全球市场。 有关更多信息，请联系: Lewis F. Neville, PhD CEO SuperTrans Medical lewis@supertransmedical.com Eran Gilboa CFO SuperTrans Medical eran@supertransmedical.com

HONG KONG, Apr 6, 2020 – (ACN Newswire) – Start-up Express, a development programme launched by the Hong Kong Trade Development Council (HKTDC) in 2018, is returning for its third edition to help local start-ups build connections, explore markets, seek partners and enhance brand awareness. Through power meet-up sessions with successful business leaders and a wide range of activities, including exploratory missions, business-matching sessions and local and overseas exhibitions, the 20 winning start-ups can explore business opportunities with potential investors and partners. HKTDC Assistant Executive Director Stephen Liang said that Start-up Express has been giving tremendous support to local start-ups…

SINGAPORE, Apr 6, 2020 – (ACN Newswire) – Fullerton Healthcare Corporation Limited (“Fullerton Health”), the leading integrated healthcare platform in the Asia Pacific, announces that it has fully redeemed its US$175 million senior perpetual capital securities today, underscoring its financial resilience and commitment to stakeholders amidst economic uncertainty arising from the COVID-19 pandemic. The redemption of the 7.0% senior perpetual capital securities (ISIN Code: XS1589875548) was made on the first call date (6 April 2020), funded by a combination of internal and external resources. The proceeds from the perpetual securities had helped Fullerton Health expand geographically, add new capabilities and service offerings, and deepen…